The Rex1GFPd2 ESCs used in the current study10 (link) were used between passage 15 and passage 25, and were cultured on 0.1% gelatin at all times in 2i medium, described in12 (link), which is N2B27 medium (Invitrogen) supplemented with MEK inhibitor (1 μM PD0325901) and GSK3 inhibitor (3 μM CHIR99021) plus Leukemia inhibitory factor (LIF). For priming/differentiation protocol, ESCs were passaged and seeded directly into N2B27 medium at a concentration of 4E5 cells/mL. The GFP signal was regularly analysed by flow cytometry using a CyAn ADP analyser (Beckman Coulter, Brea, CA, USA) to monitor Rex1 expression in the cells, and we titrated the time point of 24h after seeding in N2B27 to be T ESCs, and 48h after seeding in N2B27 to be P ESCs (Fig. 1a and Fig. S1).